John Harris, MD
Dermatology · Worcester, MANPI 1316007214
Payments from drug & device makers
Across 270 payments — averaging $63,504 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$15.6M
- LEO Pharma AS$630K
- Pfizer$372K
- Sanofi US Services Inc.$231K
- Sun Pharmaceutical Industries Inc.$132K
- EMD Serono, Inc.$89K
- plus $57K from 10 others
Across 7 payments — averaging $1345.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$9K
What the payments were for
- Consulting fees$97,9471%
- Speaking & faculty fees$54,3430%
- Travel & lodging$5,0980%
- Food & beverage$1,5180%
- Other$14,819,40499%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 175 | $15,634,731 |
| LEO Pharma AS | 4 | $630,000 |
| Pfizer | 42 | $372,386 |
| Sanofi US Services Inc. | 2 | $230,845 |
| Sun Pharmaceutical Industries Inc. | 3 | $131,533 |
| EMD Serono, Inc. | 4 | $89,366 |
| AbbVie | 16 | $30,093 |
| Almirall LLC | 7 | $9,796 |
| Regeneron | 7 | $9,147 |
| Janssen Global Services, LLC | 4 | $3,547 |
| LEO Pharma Inc. | 1 | $2,000 |
| Sanofi-aventis U.S. LLC | 1 | $1,848 |
| Merck | 1 | $750 |
| Boehringer Ingelheim | 1 | $29 |
| Boston Scientific | 1 | $26 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,146,112 in reported general payments places this provider in the 95th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Worcester
- Bassel Mahmoud AbdallahWorcester$391K
- Zainab AbbasWorcester$332K
- Mehdi Rashighi FiroozabadiWorcester$277K
- Sarah WhitleyWorcester$130K
- Seth KatesWorcester$64K
- Mark AmsterBrighton$5M
- David GreensteinBeverly$4M
- Alexandra KimballBoston$3.7M
- Robert NossaMarstons Mills$2.6M
- Gideon SmithBoston$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.